GLP-1: How Weight-Loss Drugs Are Rewriting Diagnostics Demand
- Posted on September 10, 2026
- By Google News
- 0 Views
- 1 min read
In brief
Generating AI summary…
GLP-1: How Weight-Loss Drugs Are Rewriting Diagnostics Demand
Mexico's GLP-1 expansion requires parallel diagnostic testing to track cardiometabolic outcomes effectively, writes Héctor Barillas.